Interestingly, C1q and mannose binding lectin (MBL), recognition molecules of the classical and lectin pathways of complement activation, respectively, help remove atherogenic lipoproteins56, establishing a link between C1q deficiency and cardiovascular disease development in lupus. Here, MBL2 is linked to cardiovascular disorder.